References
Volin L, Jarventie G, Ruutu T (1990) Fatal rhabdomyolysis as a complication of bone marrow transplantation. Bone Marrow Transplant 6:59–60
Sieb J, Gillesen T (2003) Iatrogenic and toxic myopathies. Muscle Nerve 27:142–156
Nava S, Fracchia C, Callegari G, Ambrosino N, Barbarito N, Felicetti G (2002) Weakness of respiratory and skeletal muscles after a short course of steroids in patients with acute lung rejection. Eur Respir J 20:497–499
Huerta-Alardín AL, Varon J, Marik PE (2005) Bench-to-bedside review: rhabdomyolysis—an overview for clinicians. Crit Care 9:158–169
Balhara KS, Highet B, Omron R (2015) Hypokalemia causing rhabdomyolysis in a patient with short bowel syndrome. J Emerg Med 48:e97–e99
Grifoni E, Fabbri A, Ciuti G, Cerinic MM, Pignone AM (2014) Hypokalemia-induced rhabdomyolysis. Intern Emerg Med 9:487–488
Horwitz H, Woeien VA, Petersen LW, Jimenez-Solem E (2015) Hypokalemia and rhabdomyolysis. J Pharmacol Pharmacother 6:98–99
Luzardo L, Silvariño R, Boggia J, Noboa O, Gadola L (2014) Severe hypokalemic rhabdomyolysis: report of six cases. Rev Med Chile 142:651–655
Maruyama F, Miyazaki H, Ezaki K, Sobue R, Tsuzuki M, Hirano M (1994) Severe rhabdomyolysis as a complication of peripheral blood stem cell transplantation. Bone Marrow Transplant 14:481–482
Hoshi S, Itoh A, Kato S, Suzuki K, Kawamura S, Orikasa S (1999) Severe rhabdomyolysis as a complication of high-dose chemotherapy in a patient with advanced testicular cancer. Int J Urol 6:56–58
Acknowledgments
The authors thank Editage for their assistance in editing this manuscript. Supported by the National Natural Science Foundation of China (Grant 81502117).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical Approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Rights and permissions
About this article
Cite this article
Jiang, Q., Zhang, B.H. Rhabdomyolysis After Allogeneic Hematopoietic Stem Cell Transplantation. Indian J Hematol Blood Transfus 32, 504–506 (2016). https://doi.org/10.1007/s12288-016-0691-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-016-0691-x